High-Flow-Sauerstofftherapie – Schritt für Schritt

Abstract

In recent years, high-flow oxygen therapy (HFNC) has become established and proven as an oxygenation method for patients with severe respiratory restrictions in most intensive care units. Advantages of this method, which is used especially for patients with hypoxaemia, are the easy application and the compliance by the patient. Devices are used which enable individual oxygen therapy by means of humidification, warming up and gas flow regulation options.

In den letzten Jahren hat sich die High-Flow-Sauerstofftherapie (HFNC) auf den meisten Intensivstationen als Oxygenierungsmethode bei respiratorisch stark eingeschränkten Patienten etabliert und bewährt. Vorteile dieses Verfahrens, das insbesondere bei Patienten mit einer Hypoxämie eingesetzt wird, sind die einfache Applikation und die gute Toleranz durch den Patienten.

Schlüsselwörter

mukoziliäre Clearance - Compliance - hyperkapnische respiratorische Insuffizienz - Befeuchterkammer - Gasfluss

Key words

mucociliary clearance - compliance - hypercapnic respiratory insufficiency - humidification chamber - gas flow

Publication History

Article published online:
19 May 2020

• Literatur

• 1 Simon M, Grensemann J, Kluge S. High-Flow-Sauerstofftherapie in der Intensivmedizin. Journal Club AINS 2018; 7: 106-116
• 2 Sztrymf B, Messika J, Bertrand F. et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med 2011; 37: 1780-1786
• 3 Luo JC, Lu MS, Zhao ZH. et al. Positive end-expiratory pressure effect of 3 high-flow nasal cannula devices. Respir Care 2017; 62: 888-895
• 4 Besnier E, Hobeika S, NSeir S. et al. High-flow nasal cannula therapy: clinical practice in intensive care units. Ann Intensive Care 2019; 9: 98
• 5 Rochwerg B, Granton D, Wang DX. et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 2019; 45: 563-572
• 6 Grensemann J, Fuhrmann V, Kluge S. Oxygen treatment in intensive care and emergency medicine. Dtsch Arztebl Int 2018; 115: 455
• 7 Chu DK, Kim LH, Young PJ. et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet 2018; 391: 1693-1705
• 8 Kotoda M. et al Assessment of the potential for pathogen dispersal during high-flow nasal therapy. J Hosp Infect 2019
• 9 Hui DS. et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019; 53 (04) 1802339
• 10 Hui DS. et al. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest 2019; 135 (03) 648-654
• 11 Leonard S. et al Preliminary Findings of Control of Dispersion of Aerosols and Droplets during High Velocity Nasal Insufflation Therapy Using a Simple Surgical Mask: Implications for High Flow Nasal Cannula. Chest 2020
• 12 Kluge S. et al. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19. Med Klin Intensivmed Notfmed 2020; 115 (03) 175-177